Drug intelligence / Profile preview

chromium-51 labelled cultured red cells

Development stage
Unknown
Lead developer
Cell Therapies
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Cell Therapies
Administration
Intravenous
01

Overview

Chromium-51 labelled cultured red cells is an investigational radiolabelled cellular product developed by Cell Therapies Pty Ltd. It consists of cultured red blood cells (cRBCs) that are labelled ex vivo with the radioactive isotope chromium-51 (51Cr) using a sterile sodium chromate solution. The product is designed for intravenous administration to evaluate the mean circulation time, biodistribution, and safety of cultured red cells in patients with low-risk myelodysplastic syndrome (MDS) or those in remission from hematologic malignancies. The chromium-51 label serves as a diagnostic tracer for in vivo tracking via gamma scintigraphy, allowing researchers to monitor the survival and movement of the infused cells.

Other names
51Cr-labelled cRBCschromium-51 labelled cRBCschromium51 labelled cRBCschromium 51 labelled cRBCs51Cr-cRBCs

Beyond the preview

Go deeper on chromium-51 labelled cultured red cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chromium-51 labelled cultured red cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call